- Language: English
- 448 Pages
- Published: April 2013
Global Metabolomics Market 2012-2016
- ID: 2365977
- December 2012
- Region: Global
- 45 pages
TechNavio's analysts forecast the Global Metabolomics market to grow at a CAGR of 14.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements in R&D activities. The Global Metabolomics market has also been witnessing the emergence of coordination of standards in metabolomics. However, the low adoption of metabolomics technology, especially among large pharmaceutical companies could pose a challenge to the small vendors and therefore the growth of this market.
TechNavio's report, the Global Metabolomics Market 2012-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., and Metabolon Inc.
The other vendors mentioned in the report are Acadia Pharmaceuticals Inc., Accelrys Inc., Amphora Discovery Corp., Applied Biosystems Group, BG Medicine Inc., Biocrates Life Sciences AG, Caliper Life Sciences Inc., Chenomx Inc., Beckman Coulter Inc., Genedata AG, GeneGo Inc., AB SCIEX LLC, Becton Dickinson and Company, Metabometrix Inc., Pharmaceutical Product Development Inc., Phenomenome Discoveries Inc., Shimadzu Corp., SiDMAP LLC, Thermo Fisher Scientific Inc., and Waters Corp.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
The report is also available as part of our annual subscription offer. Please get in touch with our customer service team in order to find out more. SHOW LESS READ MORE >
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1 Market Size
04.2 Market Forecast
04.3 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Agilent Technologies Inc.
13.2 Bruker Corp.
13.3 Bio-Rad Laboratories Inc.
13.4 Metabolon Inc.
13.5 Human Metabolome Technologies Inc.
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Metabolomics Market 2012–2016 (US$ million)
Exhibit 2: Global Metabolomics Market by Geographical Segmentation 2012
Exhibit 3: Global Metabolomics Market by Vendor Segmentation 2012
Exhibit 4: Business Segmentation of Agilent Technologies Inc.
Exhibit 5: Business Segmentation of Bruker Corp.
Exhibit 6: Business Segmentation of Bio-Rad Laboratories Inc.
Exhibit 7: Business Segmentation of Metabolon Inc.
Exhibit 8: Business Segmentation of Human Metabolome Technologies Inc.
TechNavio Announces the Publication of its Research Report - Global Metabolomics Market 2012-2016
TechNavio today launched its report, Global Metabolomics Market 2012-2016, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Recently, the Global Metabolomics market has been witnessing a significant increase in the number of product launches. For instance, Applied Biosystems inc. launched new TaqMan genotyping assays in 2009. Bio-Rad Laboratories introduced Bio-Plex Pro cell signaling assays in July 2012. Moreover, Bio-Rad introduced Bio-Plex assays for immunology and cancer biomarker research in March 2012. Bruker announced new quantitative proteomics capabilities with Skyline software in September 2012. GenoLogics Life Sciences Software Inc. announced the availability of the GenoLogics Rapid Scripting Application Programming Interface (API) for scientific programmers and bioinformaticians in February 2011.''
According to the report, most of the reputable vendors in the Global Metabolomics market are investing significantly in RandD to develop advanced technologies. Moreover, researchers from the University of Washington created disk-shaped patches to inspect the option of generating new tissues with the help of oxygen and nutrient supplies necessary for living cells. Furthermore, scientists at the University of Bristol in the UK developed new scaffolds that can be used to grow such tissues as skin, nerves, and cartilage. These significant developments and initiatives in R&D are expected to drive the growth of the Global Metabolomics market during the period 2012-2016.
Further, the report reveals that one of the major challenges for this market is the low adoption of metabolomics technology, especially among large pharmaceutical companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., Metabolon Inc., Acadia Pharmaceuticals Inc., Accelrys Inc., Amphora Discovery Corp., Applied Biosystems Group, BG Medicine Inc., Biocrates Life Sciences AG, Caliper Life Sciences Inc., Chenomx Inc., Beckman Coulter Inc., Genedata AG, GeneGo Inc., AB SCIEX LLC, Becton Dickinson and Company, Metabometrix Inc., Pharmaceutical Product Development Inc., Phenomenome Discoveries Inc., Shimadzu Corp., SiDMAP LLC, Thermo Fisher Scientific Inc., Waters Corp.